is used to express the extension of hematoma from ruptured abdominal aortic aneurysm (rAAA) and is thought to be related to patient's preoperative status. We propose a promising method of procedure selection for rAAA, either endovascular aortic repair (EVAR) or open repair, considering the Fitzgerald classification.
Methods: A retrospective multicenter study was performed with a questionnaire survey of rAAA from August 2010 to July 2015 in Hokkaido, Japan, sent to the 20 institutions of the Hokkaido Society of Aortic Stent Graft. Of 211 patients for rAAA, we analyzed 205 patients who could be stratified by the Fitzgerald classification. We categorized these patients into Fitzgerald class I and II (FI+II: n ¼ 72) and class III and IV (FIII+IV: n ¼ 133). The short-term results of both EVAR and open repair cases were examined in two categories. The EVAR patients who required open conversion (n ¼ 3) were included in the open group.
Results: In the first category (FI+II: n ¼ 72), the EVAR group (n ¼ 16) was older than the open group (n ¼ 56; 81.2 6 5.7 vs 73.4 6 10.3; P ¼ .0050), but there were no differences in gender, hypertension, renal failure, preoperative shock (systolic blood pressure <80 mm Hg), and cerebrovascular comorbidities. Operation time of the EVAR group was shorter than that of the open group (151 6 67 minutes vs 272 6 103 minutes; P < .0001). The in-hospital mortality rates of the EVAR group and the open group were 0% (0 of 16) and 21.7% (10 of 46; P ¼ .019). In the second category (FIII+IV: n ¼ 133), there was no difference in mean age between the EVAR group (n ¼ 26) and the open group (n ¼ 107; 76.2 6 9.4 vs 75.3 6 9.9; P ¼ .66). The rates of the other preoperative risk factors were also the same in both groups. As well as FI+II, operation time of the EVAR group was shorter than that of the open group (166 6 72 minutes vs 241 6 112 minutes; P ¼ .0014). The in-hospital death rates of the EVAR group and the open group were 27.0% (7 of 26) and 24.3% (26 of 107; P ¼ .78), respectively. However, when compared in the cases of Fitzgerald IV alone, the in-hospital mortality rates of the EVAR group and the open group were 100% (3 of 3) and 29.4% (5 of 17; P ¼ .049), respectively. All three patients of Fitzgerald IV treated by EVAR died of bleeding complications at postoperative day 1. Survivors of Fitzgerald IV treated by open repair included two EVAR patients who required open conversion because of uncontrollable bleeding or endoleak. Multivariate analysis showed FIII+IV was the only predictor of in-hospital mortality for all cases (odds ratio, 3.02; 95% confidence interval, 1. 23-8.27 Objectives: Preoperative type and crossmatch is often routinely ordered before elective endovascular aneurysm repair (EVAR), but the cost of this practice is high, and transfusion is rare. We therefore aimed to stratify patients by their risk of transfusion to identify a cohort in whom a type and screen would be sufficient.
Methods: We queried the targeted vascular module of the National Surgical Quality Improvement Program database for all elective EVARs from 2011 to 2015. We included only infrarenal aneurysms and excluded ruptured aneurysms and patients who received a transfusion within 72 hours preoperatively. Two-thirds of the cases were randomly assigned to a prediction cohort and one-third to a validation cohort. We created and subsequently validated a risk model for transfusion within the first 24 hours of surgery (including intraoperatively), using logistic regression. COPD, Chronic obstructive pulmonary disease.
Results: Between 2011 and 2015, 4875 patients underwent elective infrarenal EVAR, of which only 221 (4.5%) received a transfusion within 24 hours of surgery. The frequency of transfusion over the study period declined monotonously from 6.5% in 2011 to 3.2% in 2015. The factors independently associated with transfusion were preoperative hematocrit <36% (odds ratio [OR], 3.4; 95% confidence interval [CI], 2.1-5.4; P < .001), aortic diameter (per cm increase: OR, 1.2; 95% CI, 1.03-1.4; P ¼ .02), preoperative dependent functional status (OR, 2.5; 95% CI, 1.1-5.5; P ¼ .03), and chronic obstructive pulmonary disease (OR, 1.7; 95% CI, 1.04-2.9; P ¼ .04). A risk-prediction model based on these criteria (Table) produced a C statistic of 0.69 in the prediction cohort and 0.76 in the validation cohort and a Hosmer-Lemeshow goodness of fit of 0.62 and 0.14, respectively. A score of <3 of 9, corresponding to a <5% probability of transfusion, would avoid preoperative type and crossmatch in 86% of patients. Of the 4203 patients (86%) with a hematocrit >36, only six (0.1%) had a risk score >3.
Conclusions: Perioperative transfusion for EVAR is becoming increasingly uncommon and is predicted well by a transfusion risk score, or simply a hematocrit of <36. Application of this risk score would avoid unnecessary type and crossmatch in the majority of patients, leading to significant savings in both time and cost. Objectives: This study evaluated the early results of fenestrated thoracic endovascular aortic repair (fTEVAR) using physician-modified stent grafts (PMSGs) to revascularize aortic branches for acute type B aortic dissection (ABAD) with unhealthy proximal landing zone.
Methods: Twenty consecutive patients who underwent fenestrated TEVAR using PMSGs between November 2015 and December 2016 were retrospectively reviewed. Preoperative, intraoperative, and postoperative clinical data were recorded (Table) .
Results: The median patient age was 53 years old (range, 18-83 years), and 16 of the 20 (80%) patients were men. Indications were ABAD without healthy proximal landing zones included inadequate proximal landing zone (n ¼ 4), retrograde dissection extending to the left subclavian artery (LSA; n ¼ 13, (Fig, G) , and retrograde hematoma involving the LSA (n ¼ 3). Twenty PMSGs (Medtronic Valiant stent grafts, n ¼ 4; Relay thoracic stent grafts, n ¼ 10; Ankura thoracic stent grafts, n ¼ 6) were deployed. One LSA fenestration was created in 19 patients (Fig, A-F) , and one LSA fenestration combined with a left common carotid artery 
